Bridges Investment Management’s Prestige Consumer Healthcare PBH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$214K Hold
4,527
﹤0.01% 390
2026
Q1
$268K Buy
+4,527
New +$294K ﹤0.01% 356
2025
Q4
Sell
-5,235
Closed -$327K 427
2025
Q3
$327K Buy
5,235
+1,379
+36% +$96K ﹤0.01% 338
2025
Q2
$308K Buy
3,856
+82
+2% +$6.86K ﹤0.01% 342
2025
Q1
$324K Buy
3,774
+1,048
+38% +$86K ﹤0.01% 330
2024
Q4
$213K Buy
+2,726
New +$212K ﹤0.01% 389

Other funds holding PBH

Bridges Investment Management's PBH Position: Q2 2026 in Review

Bridges Investment Management held its Prestige Consumer Healthcare (PBH) position steady in Q2 2026 at 4,527 shares worth $214K. The position accounts for ﹤0.01% of the portfolio, ranked #390.

Bridges Investment Management first reported a position in PBH in Q4 2024 and has held it in 6 quarters since. The position peaked at $327K in Q3 2025. 319 funds tracked by Wall St. Rank hold PBH as of Q2 2026.

  • Bridges Investment Management held 4,527 shares of Prestige Consumer Healthcare worth $214K as of Q2 2026.
  • Bridges Investment Management left its Prestige Consumer Healthcare share count unchanged in Q2 2026.
  • Prestige Consumer Healthcare made up ﹤0.01% of Bridges Investment Management's portfolio in Q2 2026, its #390 holding.
  • Bridges Investment Management first reported a position in Prestige Consumer Healthcare in Q4 2024 and has held it in 6 quarters since.
  • Bridges Investment Management's Prestige Consumer Healthcare position peaked at $327K in Q3 2025.
  • 319 funds tracked by Wall St. Rank held Prestige Consumer Healthcare as of Q2 2026.

Based on Bridges Investment Management's 13F filing for Q2 2026, filed 7 Aug 2026.